Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neuronal injury causes cytoplasmic K+ loss, mediated by Kv2.1 potassium channels.
• Kv2.1 channel interaction with syntaxin 1A is crucial for this process.
• This interaction is a potential target for neuroprotection.

Purpose of the Study:

• To define the molecular interactions between syntaxin 1A and Kv2.1.
• To develop a small molecule inhibitor targeting this interaction.
• To evaluate the neuroprotective potential of the inhibitor.

Main Methods:

• Rational drug design to identify key binding sites.
• Synthesis and testing of a small molecule inhibitor (cpd5).
• Electrophysiology and cell survival assays in cortical neurons and brain slices.
• In vivo stroke model validation.

Main Results:

• Identified critical amino acids in Kv2.1 C-terminus for syntaxin 1A binding.
• Developed cpd5, a small molecule inhibitor of Kv2.1-syntaxin 1A interaction.
• cpd5 improved cortical neuron survival in excitotoxic injury models.
• cpd5 selectively displaced binding peptides and affected SNARE-dependent currents without altering intrinsic neuronal properties.

Conclusions:

• Syntaxin 1A plays a key role in mediating neuronal cell death via Kv2.1 channels.
• cpd5 demonstrates neuroprotective effects by inhibiting Kv2.1-syntaxin 1A interaction.
• This study validates Kv2.1-syntaxin 1A as a therapeutic target for neuroprotection.